European Medicines Agency

In addition, the building will house the European Medicines Agency from early 2014.

This drug is now approved by the European Medicines Agency.

Finally, I would just like to comment on the European Medicines Agency.

Ivabradine was approved by the European Medicines Agency in 2005.

That is why I voted for the report on the European Medicines Agency.

This report consists of a reminder of what the European Medicines Agency should be.

The European Medicines Agency has granted cilengitide orphan drug status.

The European Medicines Agency is still clearly having difficulty getting things off the ground, despite having been in existence for some years now.

I voted against the authorisation to discharge the 2009 general budget of the European Medicines Agency.

In 2009 the European Medicines Agency assessed boldo as follows:

Marketing permission was granted by the European Medicines Agency in August 2006.

The European medicines agency gave the green light to a US plant owned by Genzyme.

The setting up of a paediatric committee as part of the European Medicines Agency will help monitor scientific research in this area.

That being said, a number of agencies manifestly continue to be effective, on the model of the European Medicines Agency.

The European Medicines Agency has classified the gadolinium-containing contrast agents into three risk groups:

In December 2010 an advisory panel to the European Medicines Agency recommended approval of the drug.

The European Medicines Agency said yesterday that its advisory committee recommended against approval because too few patients undergoing surgery were tested.

In July 2008, the company filed a marketing authorisation application with the European Medicines Agency.

The European Medicines Agency is evaluating conditional approval for Oncophage.

European Medicines Agency.

On 23 June 2011, the European Medicines Agency concluded the review of systemic nimesulide-containing medicine.

Ombrabulin was granted orphan drug status by the European Medicines Agency in April 2011.

As a consequence, the European Medicines Agency recommended to withdraw the marketing approval in April 2010.

In 2011 they submitted an application for their drug termed Selincro to the European Medicines Agency.

The current president of the society is Stella Blackburn from the European Medicines Agency.